Ironwood Pharmaceuticals to Present at the 2019 Bank of America Merrill Lynch Healthcare Conference
May 07 2019 - 4:05PM
Business Wire
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present
a corporate update at the 2019 Bank of America Merrill Lynch
Healthcare Conference on Tuesday, May 14, 2019 at 8:00 a.m. Pacific
Time at The Encore Hotel in Las Vegas.
A live webcast of Ironwood’s presentation will be accessible
through the Investors section of the company’s website at
www.ironwoodpharma.com. To access the webcast, please log on to the
Ironwood website approximately 15 minutes prior to the start time
to ensure adequate time for any software downloads that may be
required. A replay of the webcast will be available on Ironwood’s
website for 14 days following the conference.
About Ironwood PharmaceuticalsIronwood Pharmaceuticals
(Nasdaq: IRWD) is a GI-focused healthcare company dedicated to
creating medicines that make a difference for patients living with
GI diseases. We discovered, developed and are commercializing
linaclotide, the U.S. branded prescription market leader for adults
with irritable bowel syndrome with constipation (IBS-C) or chronic
idiopathic constipation (CIC). We are currently advancing a Phase
IIIb trial evaluating the efficacy and safety of linaclotide on
multiple abdominal symptoms, including pain, bloating and
discomfort, in adult patients with IBS-C.
We are also advancing two late-stage, first-in-category GI
product candidates: IW-3718 is a gastric retentive formulation of a
bile acid sequestrant being developed for the potential treatment
of persistent gastroesophageal reflux disease, and MD-7246 is a
delayed-release formulation of linaclotide that is being evaluated
as an oral, intestinal, non-opioid, pain-relieving agent for
patients suffering from abdominal pain associated with IBS with
diarrhea.
Ironwood was founded in 1998 and is headquartered in Cambridge,
Mass. For more information, please visit our newly launched website
at www.ironwoodpharma.com or www.twitter.com/ironwoodpharma;
information that may be important to investors will be routinely
posted in both these locations.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190507005782/en/
Meredith Kaya, 617-374-5082Vice President, Investor Relations
and Corporate Communicationsmkaya@ironwoodpharma.com
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ironwood Pharmaceuticals (NASDAQ:IRWD)
Historical Stock Chart
From Jul 2023 to Jul 2024